Table 2. Sensitivity estimates for each subgroup on a per-lesion basis.
Subgroup | No. of Studies | Mean Sensitivity (%) | P Value |
Lesion size | |||
<10 mm | 6 | 79(72–85) | 0.437 |
≥10 mm | 6 | 97(95–99) | 0.323 |
<10 mm vs. ≥10 mm | NA | NA | 0.011 |
magnetic field strength | |||
1.5T | 7 | 94(91–95) | 0.077 |
3.0T | 7 | 93(90–94) | 0.001 |
1.5T vs. 3.0T | NA | NA | 0.879 |
Study design | |||
retrospective | 12 | 94(92–95) | 0.001 |
prospective | 1 | 87 | NA |
retrospective vs. prospective | NA | NA | 0.082 |
Patient Spectrum | |||
CRLM | 6 | 94(92–96) | 0.071 |
liver metastases | 7 | 91(88–94) | 0.014 |
CRLM vs. liver metastases | NA | NA | 0.289 |
Note.–Numbers in parentheses are the 95% CIs. NA = not applicable. CRLM = colorectal liver metastases.